Dr. Reddy's Laboratories gains on launching B2B customer service portal ‘XCEED’

19 Mar 2019 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 2696.00, up by 26.55 points or 0.99% from its previous closing of Rs. 2669.45 on the BSE.

The scrip opened at Rs. 2669.65 and has touched a high and low of Rs. 2707.00 and Rs. 2669.65 respectively. So far 10236 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2875.00 on 04-Feb-2019 and a 52 week low of Rs. 1888.00 on 21-May-2018.

Last one week high and low of the scrip stood at Rs. 2708.50 and Rs. 2616.55 respectively. The current market cap of the company is Rs. 44821.20 crore.

The promoters holding in the company stood at 26.77%, while Institutions and Non-Institutions held 45.67% and 13.94% respectively.

Dr. Reddy's Laboratories has launched B2B customer service portal ‘XCEED’ to increase the operational efficiency. The portal is focused on meeting the growing demand for the company’s portfolio of generic active pharmaceutical ingredients (APIs).

The platform will be presented for the first time to customers during DCAT week in New York from March 18 to 21, 2019 and will be available to API customers across the globe during the next week.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1251.10 4.85 (0.39%)
10-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.25
Dr. Reddys Lab 1251.10
Cipla 1489.15
Zydus Lifesciences 923.70
Lupin 2055.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×